AR420626, a selective agonist of G-protein coupled receptor GPR41/FFA3, suppressed the growth of HCC cells by inducing apoptosis thereby reducing the expression of HDAC2-7 with an increase in histone H3 acetylation [94]. The gene discussed is HDAC2; the disease is hepatocellular carcinoma.